Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Induction of Encephalitis in Rhesus Monkeys Infused with Lymphocryptovirus-Infected B-Cells Presenting MOG34-56 Peptide.
Low myo-inositol indicating astrocytic damage in a case series of NMO.
Patients with neuromyelitis optica have a more severe disease than patients with relapsingremitting multiple sclerosis, including higher risk of dying of a demyelinating disease.
Use of altered informed consent in pragmatic clinical research.
Interleukin-7 Receptor Single Nucleotide Polymorphism rs6897932 (C/T) and the Susceptibility to Systemic Lupus Erythematosus.
Hes3 expression in the adult mouse brain is regulated during demyelination and remyelination.
Multiple Sclerosis Associated Risk Factors: A Case-Control Study.
TNF receptor 2 protects oligodendrocyte progenitor cells against oxidative stress.
Automated brain volumetrics in multiple sclerosis: a step closer to clinical application.
Thalamo-striato-cortical determinants to fatigue in multiple sclerosis.
Quantitative benefit-risk assessment of methylprednisolone in multiple sclerosis relapses.
Structural Brain Network Characteristics Can Differentiate CIS from Early RRMS.
Combined central and peripheral demyelination.
Clinical and imaging findings in three patients with advanced inflammatory demyelinating polyradiculoneuropathy associated with nerve root hypertrophy.
Myelin oligodendrocyte glycoprotein (MOG35-55)-induced experimental autoimmune encephalomyelitis is ameliorated in interleukin-32 alpha transgenic mice.
Categorical change in T2 lesion volume and clinical outcomes in the Phase III FREEDOMS and its extension study, evaluating fingolimod in patients with relapsing-remitting multiple sclerosis.
Depressive state and chronic fatigue in multiple sclerosis and neuromyelitis optica.
Site-Specific Chemokine Expression Regulates Central Nervous System Inflammation and Determines Clinical Phenotype in Autoimmune Encephalomyelitis.
The multiple faces of RAGE - opportunities for therapeutic intervention in aging and chronic disease.
FDG PET/CT in Acute Tumefactive Multiple Sclerosis Occurring in a Case of Chronic Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation.
Dietary Luteolin Reduces Proinflammatory Microglia in the Brain of Senescent Mice.
Obstructive Sleep Apnea is an Under-Recognized and Consequential Morbidity in Multiple Sclerosis.
Development and validation of an ELISA for quantification of soluble IFN-β receptor: assessment in multiple sclerosis.
The role of pro- and anti-inflammatory cytokines in the pathogenesis of spontaneous canine CNS diseases.
Repeatability of quantitative sodium magnetic resonance imaging for estimating pseudo-intracellular sodium concentration and pseudo-extracellular volume fraction in brain at 3 T.
Pages
« first
‹ previous
…
612
613
614
615
616
617
618
619
620
…
next ›
last »